Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrolBMC Cancer, 2015, 15 (1), pp.873. ⟨10.1186/s12885-015-1909-2⟩
Journal articles
inserm-01264476v1
|
||
Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistanceAnti-Cancer Drugs, 2018, 29 (8), pp.748-755. ⟨10.1097/CAD.0000000000000647⟩
Journal articles
inserm-02402025v1
|
|||
|
HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.Molecular Cancer, 2010, 9 (1), pp.79. ⟨10.1186/1476-4598-9-79⟩
Journal articles
inserm-00668221v1
|